Beijing Hotgen Biotech Co Ltd Capital Reinvestment Ratio
Beijing Hotgen Biotech Co Ltd capital reinvestment ratio. Beijing Hotgen Biotech Co Ltd (688068) has a Capital Reinvestment Ratio of 4.82x as of September 2025, meaning it reinvests 5% of its operating cash flow (CN¥3.05 Million) in capital expenditures (CN¥14.73 Million). Check Beijing Hotgen Biotech Co Ltd (688068) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Beijing Hotgen Biotech Co Ltd (2016–2022)
Capital reinvestment ratio of Beijing Hotgen Biotech Co Ltd from 2016 to 2022. This chart tracks Beijing Hotgen Biotech Co Ltd's Capital Reinvestment Ratio across 7 annual periods. Also explore Beijing Hotgen Biotech Co Ltd (688068) equity growth momentum to track the company's year-over-year net asset growth rate.
Beijing Hotgen Biotech Co Ltd Capital Reinvestment Ratio by Year (2016–2022)
Beijing Hotgen Biotech Co Ltd capital reinvestment ratio by year from 2016 to 2022. For the full cash flow conversion analysis, see 688068 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.58x | CN¥978.75 Million | CN¥565.21 Million | ▲ +282.9% |
| 2021 | 0.15x | CN¥2.64 Billion | CN¥398.86 Million | ▼ -85.6% |
| 2020 | 1.05x | CN¥164.62 Million | CN¥172.27 Million | ▼ -77.1% |
| 2019 | 4.57x | CN¥19.37 Million | CN¥88.48 Million | ▲ +498.5% |
| 2018 | 0.76x | CN¥55.04 Million | CN¥42.00 Million | ▼ -74.6% |
| 2017 | 3.01x | CN¥22.95 Million | CN¥69.05 Million | ▲ +546.9% |
| 2016 | 0.47x | CN¥45.54 Million | CN¥21.18 Million | — |